• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Andrographolide Targets SDHA to Boost Cancer Drug Sensitivity

by
November 7, 2026
in Biology
Reading Time: 3 mins read
0
Andrographolide Targets SDHA to Boost Cancer Drug Sensitivity

Andrographolide Targets SDHA to Boost Cancer Drug Sensitivity

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers have identified andrographolide, a natural diterpenoid derived from the plant Andrographis paniculata, as the first reported small-molecule compound that directly targets succinate dehydrogenase complex flavoprotein subunit A (SDHA). Published in Cellular & Molecular Biology Letters, the study demonstrates that this interaction disrupts the assembly of SDHA with succinate dehydrogenase complex assembly factor 4 (SDHAF4), thereby compromising mitochondrial metabolic homeostasis. This disruption promotes ferroptosis, an iron-dependent and lipid peroxidation-driven form of regulated cell death, and significantly enhances the sensitivity of triple-negative breast cancer (TNBC) cells to doxorubicin (DOX), a standard chemotherapy agent to which TNBC is often refractory.

The study addresses a critical gap in oncology where TNBC remains highly resistant to anthracyclines like doxorubicin due to apoptosis-associated resistance mechanisms. While ferroptosis has emerged as a promising strategy to circumvent this apoptotic escape, clinically actionable targets for inducing this form of cell death in TNBC have remained poorly defined. Specifically, the role of mitochondrial complex II assembly in governing ferroptosis and chemoresistance had not been previously elucidated, and no small-molecule compound had been reported to directly target SDHA or disrupt its interaction with SDHAF4.

To identify the molecular target of andrographolide, the researchers employed a suite of biochemical and biophysical techniques, including drug affinity responsive target stability (DARTS), cellular thermal shift assay (CETSA), and mass spectrometry. Further validation was achieved through pull-down assays, surface plasmon resonance (SPR), and molecular docking simulations. The disruption of the SDHA–SDHAF4 complex was examined using co-immunoprecipitation and molecular dynamics simulation, while nuclear protein isolation and confocal microscopy were utilized to determine nuclear localization. Additionally, protein succinylation was analyzed to understand post-translational modifications associated with the compound’s activity. Ferroptosis responses were comprehensively assessed through transmission electron microscopy, lipid peroxidation assays, and measurements of intracellular Fe2+, malondialdehyde (MDA), glutathione (GSH), and reactive oxygen species (ROS).

The results revealed that andrographolide potently induced ferroptosis, inhibited TNBC cell proliferation, and enhanced DOX sensitivity in both two-dimensional TNBC cell lines and three-dimensional patient-derived organoids. Mechanistically, andrographolide increased lipid peroxidation, Fe2+ accumulation, ROS, and MDA levels, effects that were attenuated by ferroptosis inhibitors or ROS scavengers. Structural and biochemical analyses indicated that andrographolide binds at Arg451 and His407 on SDHA, disrupting the SDHA–SDHAF4 interaction. This binding impairs SDHA maturation and destabilizes complex II assembly, identifying SDHA as a direct molecular target of the compound. In vivo studies further demonstrated that andrographolide synergized with doxorubicin to suppress TNBC tumor growth without detectable systemic toxicity.

Importantly, the study is the first to demonstrate that the integrity of SDHA–SDHAF4 assembly serves as a critical metabolic checkpoint governing ferroptosis sensitivity and chemoresistance. Disruption of this assembly triggered two convergent ferroptotic signals: excessive ROS generation and succinate accumulation-mediated Keap1 succinylation. The findings suggest that the stability of the SDHA–SDHAF4 complex is not merely a structural feature but a functional regulator of mitochondrial metabolic homeostasis that influences the susceptibility of cancer cells to ferroptotic cell death.

Similar chemosensitizing effects of andrographolide were observed in lung and stomach cancer models, consistent with the broader implications of SDHA targeting in chemoresistant cancers. Notably, SDHA knockdown further amplified andrographolide-induced ferroptosis, reinforcing the central role of SDHA in the compound’s mechanism of action. These observations highlight a previously unrecognized SDHA-centered metabolic vulnerability that can be therapeutically exploited to induce ferroptosis and overcome doxorubicin resistance in TNBC.

The study concludes that andrographolide represents a novel natural small-molecule inhibitor that targets SDHA and disrupts SDHA–SDHAF4 assembly. By revealing that SDHA–SDHAF4 complex integrity governs ferroptosis susceptibility and anthracycline resistance, the research uncovers a new avenue for therapeutic intervention in triple-negative breast cancer. The ability of andrographolide to enhance doxorubicin sensitivity without significant systemic toxicity suggests its potential as a chemosensitizer in combination therapy.

Subject of Research: Mechanistic role of andrographolide in targeting SDHA to induce ferroptosis in triple-negative breast cancer

Article Title: Andrographolide disrupts SDHA–SDHAF4 assembly-mediated mitochondrial metabolic homeostasis to promote ferroptosis and doxorubicin sensitivity in triple-negative breast cancer

Article References: Feng, Z., Zhao, P., Cui, H., Choi, S. B., Zhou, T., Hong, Y., Zhou, L., Chen, M., Song, H., Hao, X., & Yang, J. (2026). Andrographolide disrupts SDHA–SDHAF4 assembly-mediated mitochondrial metabolic homeostasis to promote ferroptosis and doxorubicin sensitivity in triple-negative breast cancer. Cellular & Molecular Biology Letters. https://doi.org/10.1186/s11658-026-01016-5

Image Credits: AI Generated

DOI: 10.1186/s11658-026-01016-5

Keywords: triple-negative breast cancer, andrographolide, ferroptosis, SDHA, SDHAF4, doxorubicin, mitochondrial metabolism, chemoresistance, small-molecule inhibitor, Cellular & Molecular Biology Letters, disrupts, assembly-mediated

News Source: Nathaniel Bowman. (November 7, 2026). Andrographolide Targets SDHA to Boost Cancer Drug Sensitivity. Scienmag.

Tags: andrographolideassembly-mediatedCellular & Molecular Biology Letterschemoresistancedisruptsdoxorubicinferroptosismitochondrial metabolismSDHASDHAF4small-molecule inhibitortriple-negative breast cancer
Share12Tweet7Share2ShareShareShare1

Related Posts

Lineage-Specific Genes Underlie Rapid Leaf Movement in Sensitive Mimosa Species

Lineage-Specific Genes Underlie Rapid Leaf Movement in Sensitive Mimosa Species

November 18, 2026
Loss of Peroxisomal Acyl-CoA Oxidase Alters Mitochondrial and Lipid Dynamics in Yeast

Loss of Peroxisomal Acyl-CoA Oxidase Alters Mitochondrial and Lipid Dynamics in Yeast

November 18, 2026

Olfactory Bulb Alpha-Synuclein Contributes to Amygdala Accumulation and Behavioral Changes in Mice

November 18, 2026

Study Identifies Three Distinct Health Profiles Among Adults Seeking Autism-Affirming Telehealth

November 18, 2026

POPULAR NEWS

  • Copper Nanoparticles Enhance Corrosion Resistance in Direct-to-Metal Coatings

    Copper Nanoparticles Enhance Corrosion Resistance in Direct-to-Metal Coatings

    29 shares
    Share 12 Tweet 7
  • Electroacupuncture Modulates Hippocampal RNA Fusion Transcripts in Traumatic Brain Injury Rats

    29 shares
    Share 12 Tweet 7
  • Combined Malnutrition and Poor Quality of Life Elevate Digestive Cancer Mortality

    29 shares
    Share 12 Tweet 7
  • Meta-Learning Accelerates Microwave Hyperthermia Antenna Optimization in Proof-of-Concept Study

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Dual-Stream Swin Transformer Reaches 96 Percent Accuracy Detecting Student Emotions

Systematic Review Finds Adolescent Malnutrition Disparities Widening Across Global Socioeconomic Gradients

Precast Concrete Panels Restore Seismic Resilience in Corroded Underground Infrastructure

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.